BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3008665)

  • 1. [Possible modes of action of growth factors and tumor promoters in the activation of the c-myc gene in Swiss 3T3 fibroblasts].
    Takai Y; Kaibuchi K; Tsuda T; Yamashita T; Kikuchi A; Tanimoto T; Hoshijima M
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):798-805. PubMed ID: 3008665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibroblast growth factor stimulates protein kinase C in quiescent 3T3 cells without Ca2+ mobilization or inositol phosphate accumulation.
    Nånberg E; Morris C; Higgins T; Vara F; Rozengurt E
    J Cell Physiol; 1990 May; 143(2):232-42. PubMed ID: 2159012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bombesin induction of c-fos and c-myc proto-oncogenes in Swiss 3T3 cells: significance for the mitogenic response.
    Rozengurt E; Sinnett-Smith JW
    J Cell Physiol; 1987 May; 131(2):218-25. PubMed ID: 3108267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Large induction of c-Myc is not essential for the mitogenic response of Swiss 3T3 fibroblasts.
    Mehmet H; Littlewood TD; Sinnett-Smith J; Moore JP; Evan GI; Rozengurt E
    Cell Growth Differ; 1997 Feb; 8(2):187-93. PubMed ID: 9040940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential induction of c-fos and c-myc by cyclic AMP in Swiss 3T3 cells: significance for the mitogenic response.
    Mehmet H; Sinnett-Smith J; Moore JP; Evan GI; Rozengurt E
    Oncogene Res; 1988; 3(3):281-6. PubMed ID: 2462705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible involvement of protein kinase C and calcium ion in growth factor-induced expression of c-myc oncogene in Swiss 3T3 fibroblasts.
    Kaibuchi K; Tsuda T; Kikuchi A; Tanimoto T; Yamashita T; Takai Y
    J Biol Chem; 1986 Jan; 261(3):1187-92. PubMed ID: 3080420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immediate early gene expression in dog thyrocytes in response to growth, proliferation, and differentiation stimuli.
    Deleu S; Pirson I; Clermont F; Nakamura T; Dumont JE; Maenhaut C
    J Cell Physiol; 1999 Nov; 181(2):342-54. PubMed ID: 10497313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An intermediary role of proHB-EGF shedding in growth factor-induced c-Myc gene expression.
    Nanba D; Inoue H; Shigemi Y; Shirakata Y; Hashimoto K; Higashiyama S
    J Cell Physiol; 2008 Feb; 214(2):465-73. PubMed ID: 17674363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastrin-releasing peptide receptor-induced internalization, down-regulation, desensitization, and growth: possible role for cyclic AMP.
    Benya RV; Fathi Z; Kusui T; Pradhan T; Battey JF; Jensen RT
    Mol Pharmacol; 1994 Aug; 46(2):235-45. PubMed ID: 8078487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of the Balb/c-3T3 cell cycle-effects of growth factors.
    Stiles CD; Pledger WJ; Tucker RW; Martin RG; Scher CD
    J Supramol Struct; 1980; 13(4):489-99. PubMed ID: 6453256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sprouty2 downregulation plays a pivotal role in mediating crosstalk between TGF-beta1 signaling and EGF as well as FGF receptor tyrosine kinase-ERK pathways in mesenchymal cells.
    Ding W; Shi W; Bellusci S; Groffen J; Heisterkamp N; Minoo P; Warburton D
    J Cell Physiol; 2007 Sep; 212(3):796-806. PubMed ID: 17516543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effect of FGF and PDGF on cell proliferation and migration in osteoblastic cells.
    Kim SJ; Kim SY; Kwon CH; Kim YK
    Growth Factors; 2007 Apr; 25(2):77-86. PubMed ID: 17852407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of cell growth: effects of the tyrosine kinase inhibitor CGP 53716.
    Major TC; Keiser JA
    J Pharmacol Exp Ther; 1997 Oct; 283(1):402-10. PubMed ID: 9336349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of stress-activator protein kinase/c-Jun N-terminal kinase by the non-TPA-type tumor promoter palytoxin.
    Kuroki DW; Bignami GS; Wattenberg EV
    Cancer Res; 1996 Feb; 56(3):637-44. PubMed ID: 8564984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential regulation of cell growth and gene expression by FGF-2 and FGF-4 in pituitary lactotroph GH4 cells.
    Jackson TA; Koterwas DM; Bradford AP
    Mol Cell Endocrinol; 2006 Mar; 247(1-2):183-91. PubMed ID: 16469431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The activation and composition of FiRE (an FGF-inducible response element) differ in a cell type- and growth factor-specific manner.
    Jaakkola P; Määttä A; Jalkanen M
    Oncogene; 1998 Sep; 17(10):1279-86. PubMed ID: 9771971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitors of calcineurin block expression of cyclins A and E induced by fibroblast growth factor in Swiss 3T3 fibroblasts.
    Tomono M; Toyoshima K; Ito M; Amano H; Kiss Z
    Arch Biochem Biophys; 1998 May; 353(2):374-8. PubMed ID: 9606972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclic AMP does not mediate inhibition of DNA synthesis by interferon in mouse Swiss 3T3 cells.
    Ebsworth NM; Taylor-Papadimitriou J; Rozengurt E
    J Cell Physiol; 1984 Aug; 120(2):146-50. PubMed ID: 6204998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FGF-2, IL-1beta and TGF-beta regulate fibroblast expression of S100A8.
    Rahimi F; Hsu K; Endoh Y; Geczy CL
    FEBS J; 2005 Jun; 272(11):2811-27. PubMed ID: 15943814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mouse 3T3-L1 cell variants unable to respond to mitogenic stimulation of dihydroteleocidin B: genetic evidence for the synergism of tumor promoters with growth factors.
    Shimizu Y; Fujiki H; Sugimura T; Shimizu N
    Cancer Res; 1986 Aug; 46(8):4027-31. PubMed ID: 3015382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.